SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-241067
Filing Date
2024-10-22
Accepted
2024-10-22 16:15:58
Documents
2
Group Members
JOSEPH EDELMANPERCEPTIVE LIFE SCIENCES MASTER FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G d829059dsc13g.htm SC 13G 60975
2 EX-99.1 d829059dex991.htm EX-99.1 5030
  Complete submission text file 0001193125-24-241067.txt   67671
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Subject) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92155 | Film No.: 241386497
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)